Totsuka Y, Takamura-Enya T, Nishigaki R, Sugimura T, Wakabayashi K
Cancer Prevention Basic Research Project, National Cancer Center Research Institute, 1-1 Tsukiji 5-chome, Chuo-ku, Tokyo 104-0045, Japan.
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Mar 25;802(1):135-41. doi: 10.1016/j.jchromb.2003.10.041.
Norharman, widely distributed in our environment such as cigarette smoke and cooked foods, is not mutagenic to Salmonella strains, but becomes mutagenic to Salmonella typhimurium TA98 and YG1024 with S9 mix in the presence of aromatic amines, including aniline and o-toluidine. Therefore, we have designated norharman as a "co-mutagen". Since, humans are simultaneously exposed to norharman and aromatic amines in daily life, it is important to clarify the mechanisms of its co-mutagenic action to further understanding of the potential genotoxic effects in humans. Regarding the mechanisms of this action of norharman with aniline, a mutagenic compound, 9-(4'-aminophenyl)-9H-pyrido[3,4-b]indole[aminophenylnorharman (APNH)] is produced by their interaction, and converted to the hydroxyamino derivative which eventually forms the DNA adduct, dG-C8-APNH through possible ultimate reactive forms with esterification, and this induces mutations. Also other aminophenyl-beta-carboline compounds, such as 9-(4'-amino-3'-methylphenyl)-9H-pyrido[3,4-b]indole[amino-3'-methylphenylnorharman (3'-AMPNH)], 9-(4'-amino-2'-methylphenyl)-9H-pyrido[3,4-b]indole [amino-2'-methylphenylnorharman (2'-AMPNH)], 9-(4'-aminophenyl)-1-methyl-9H-pyrido[3,4-b]indole[aminophenylharman (APH)] and 9-(4'-amino-3'-methylphenyl)-1-methyl-9H-pyrido[3,4-b]indole[amino-3'-methylphenylharman (AMPH)], have been found on reaction of norharman or harman with aniline or toluidine isomers. These compounds showed mutagenic and clastogenic actions in bacterial and mammalian cells. Among them, APNH demonstrated the most potent activity, and it was most extensively studied. When APNH was administered as a single dose to F344 rats, severe testicular toxicity was observed after 6 days. Moreover, liver preneoplastic lesions (GST-P-positive foci) in the liver clearly developed in animals fed 10-50 ppm of APNH in the diet for 4 weeks. Since, APNH was detected in 24 h urine of rats upon simultaneous administration with norharman and aniline by gavage, it is likely to be also produced from norharman and aniline in the human body. From these findings, it is suggested that aminophenyl-beta-carboline derivatives may be classified as one of the novel types of endogenous mutagens and carcinogens.
去甲哈尔满广泛分布于我们的环境中,如香烟烟雾和烹饪食品中,它对沙门氏菌菌株无致突变性,但在存在包括苯胺和邻甲苯胺在内的芳香胺时,与S9混合液一起会对鼠伤寒沙门氏菌TA98和YG1024产生致突变性。因此,我们将去甲哈尔满指定为“共诱变剂”。由于人类在日常生活中同时接触去甲哈尔满和芳香胺,阐明其共诱变作用机制对于进一步了解对人类潜在的遗传毒性效应非常重要。关于去甲哈尔满与诱变化合物苯胺的这种作用机制,它们相互作用会产生9-(4'-氨基苯基)-9H-吡啶并[3,4-b]吲哚[氨基苯基去甲哈尔满(APNH)],并转化为羟基氨基衍生物,最终通过可能的最终反应形式经酯化形成DNA加合物dG-C8-APNH,这会诱导突变。此外,在去甲哈尔满或哈尔满与苯胺或甲苯胺异构体反应时还发现了其他氨基苯基-β-咔啉化合物,如9-(4'-氨基-3'-甲基苯基)-9H-吡啶并[3,4-b]吲哚[氨基-3'-甲基苯基去甲哈尔满(3'-AMPNH)]、9-(4'-氨基-2'-甲基苯基)-9H-吡啶并[3,4-b]吲哚[氨基-2'-甲基苯基去甲哈尔满(2'-AMPNH)]、9-(4'-氨基苯基)-1-甲基-9H-吡啶并[3,4-b]吲哚[氨基苯基哈尔满(APH)]和9-(4'-氨基-3'-甲基苯基)-1-甲基-9H-吡啶并[3,4-b]吲哚[氨基-3'-甲基苯基哈尔满(AMPH)]。这些化合物在细菌和哺乳动物细胞中表现出致突变和染色体断裂作用。其中,APNH表现出最强的活性,并且对其研究最为广泛。当将APNH以单剂量给予F344大鼠时,6天后观察到严重的睾丸毒性。此外,在饮食中摄入10 - 50 ppm APNH 4周的动物肝脏中明显出现了肝脏癌前病变(GST-P阳性灶)。由于在通过灌胃同时给予去甲哈尔满和苯胺后,在大鼠的24小时尿液中检测到了APNH,所以它很可能也在人体中由去甲哈尔满和苯胺产生。从这些发现表明,氨基苯基-β-咔啉衍生物可能被归类为新型内源性诱变剂和致癌物之一。